DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
05/04/2023* 09:00 EST Earnings Call Q1 2023 -- -- --
05/03/2023* -- Results Q1 2023 -- 0.71 --
02/28/2023 08:00 EST Earnings Call Q4 2022 -- -- --
02/27/2023 -- Results Q4 2022 0.74 0.75 -1.19%
11/01/2022 09:00 EST Earnings Call Q3 2022 -- -- --
10/31/2022 -- Results Q3 2022 1.64 0.79 108.6%
07/28/2022 09:00 EST Earnings Call Q2 2022 -- -- --
07/27/2022 -- Results Q2 2022 0.84 0.78 7.99%
*Estimated Date/Time

Earnings

Next Report Date 05/03/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 02/27/2023
Beat/Miss Upgrade
Return Since -12.05%
Last FQE 12/31/2022
Next FQE 03/31/2023

Profile

Edit
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
URL https://www.acadiahealthcare.com
Investor Relations URL https://www.acadiahealthcare.com/investors/
HQ State/Province Tennessee
Sector Healthcare
Industry Medical Care Facilities
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 27, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Annual Total Returns Versus Peers

Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
-47.01%
-1.42%
-21.21%
29.21%
51.29%
20.77%
35.62%
-14.01%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
3.87%
-51.02%
2.16%
13.06%
121.9%
5.00%
104.6%
-40.27%
12.65%
-10.68%
6.93%
3.17%
23.62%
-4.00%
-5.17%
9.38%
-12.08%
9.45%
18.67%
43.38%
20.25%
11.64%
57.59%
-5.65%
6.30%
-74.40%
-23.79%
-33.80%
2.84%
156.2%
79.14%
-67.54%
7.64%
As of March 28, 2023.

Profile

Edit
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
URL https://www.acadiahealthcare.com
Investor Relations URL https://www.acadiahealthcare.com/investors/
HQ State/Province Tennessee
Sector Healthcare
Industry Medical Care Facilities
Equity Style Mid Cap/Blend
Next Earnings Release May. 03, 2023 (est.)
Last Earnings Release Feb. 27, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
DWEQ 746357.0 USD 2.41%
QMOM 2.606M USD 2.05%
XMMO 20.18M USD 1.95%
XHS 1.869M USD 1.76%
XMHQ 6.703M USD 1.42%
IHF 16.12M USD 1.37%
DIGGX 47.62M USD 1.31%
JGLYX 46.62M USD 1.14%
FCCGX 43.82M USD 0.90%
DFSVX 114.69M USD 0.77%
VEXPX 138.09M USD 0.68%
DFTVX 61.45M USD 0.48%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ACHC Tweets